Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

How COVID-19 impacted people with progressive multiple sclerosis

Staff Writer
Staff Writer 2 years ago
Updated 2020/09/14 at 11:36 PM
Share
SHARE

Since the SARS-CoV-2 pandemic began to worsen in early-2020, numerous studies have been released probing the impact of the coronavirus on mental health. In a new study, released online in the Journal of Neurology, a team of researchers associated with the Kessler Foundation showed the impact COVID-19 had on people with progressive multiple sclerosis (PMS).

For the new study, researchers gathered data of 131 patients with PMS as part of a randomized clinical trial on rehabilitation based in more than 10 centers in the U.S. and Europe. All restrictions and procedures put forth by top health officials, regardless of interruption to their study, were implemented during the COVID-19 pandemic.

A survey through either electronic communication, via telephone or email, was given to all of the participants to assess mental health, quality of life, and symptoms associated with multiple sclerosis.

According to researchers, only an infinitesimal number of participants were confirmed to have been infected by COVID-19; however, all in all, there was only minimal impact on psychological health and overall quality of life.


“Most participants reported the impact of the virus on their psychological well-being, with a little impact on financial well-being. The perceived impact of the pandemic on physical and psychological well-being was correlated with the impact of MS symptomatology on daily life, as well as changes in depression,” the co-authors inferred in their journal article.

“Overall, little change was noted in symptoms of depression or anxiety or overall quality of life.”

Photo: iStock

You Might Also Like

New study explores test that can detect Alzheimer’s years before diagnosis

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

New research finds Alzheimer’s risk factors affect males and females very differently

Study establishes critical role in regulating excessive folding of gyri in brain

TAGGED: COVID-19, multiple sclerosis, pandemia
Staff Writer September 14, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Measuring brainwaves during REM sleep could predict treatment response to antidepressants
Next Article People who experience PTSD may be at a higher risk of dementia

Recommended

Clinical

New study explores test that can detect Alzheimer’s years before diagnosis

1 Min Read
Clinical

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

1 Min Read
Clinical

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

1 Min Read
Clinical

New research finds Alzheimer’s risk factors affect males and females very differently

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?